Results for
""Device Approval""[mesh_terms]

Vagus nerve stimulation in pediatric epilepsy: a review.

I Valencia, D L Holder, S L Helmers, J R Madsen, J J Riviello

Pediatric neurology 2002;25(5):368-76

Evaluation of Bioequivalence Between the New Procaterol Hydrochloride Hydrate Dry Powder Inhaler and the Approved Dry Powder Inhaler in Patients With Asthma in a Randomized, Double-Blind, Double-Dummy, Crossover Comparison Study: A Phase 3 Study.

Kyoko Sato, Yuko Takeuchi, Issei Tokimatsu, Nobuyuki Koga, Junichi Kadota, Kyoichi Ohashi, Yuki Suzaki, Ryo Shirai

Clinical pharmacology in drug development 2019;7(4):392-399

Obesity medications: what does the future look like?

W Scott Butsch

Current opinion in endocrinology, diabetes, and obesity 2016;22(5):360-6

Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges.

Therese M Heinonen, Maira Aamer, Cameron Marshall, Donald M Black, Jean-Claude Tardif

Expert review of cardiovascular therapy 2013;10(8):989-94

Intragastric balloons: a temporary treatment for obesity.

C Allison

Issues in emerging health technologies 2006

Benefit-risk paradigm for clinical trial design of obesity devices: FDA proposal.

Herbert Lerner, Joyce Whang, Rebecca Nipper

Surgical endoscopy 2013;27(3):702-7

Accelerated partial breast irradiation as sole radiotherapy after breast-conserving surgery for early stage breast cancer.

Technology Evaluation Center Assessment Program. Executive summary 2007;22(4):1-4

Inter-Laboratory Characterization of the Velocity Field in the FDA Blood Pump Model Using Particle Image Velocimetry (PIV).

Martin Buesen, Prasanna Hariharan, Kenneth I Aycock, Steven W Day, Bryan C Good, Luke H Herbertson, Ulrich Steinseifer, Keefe B Manning, Brent A Craven, Richard A Malinauskas

Cardiovascular engineering and technology 2019;9(4):623-640